工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Isolation, expansion, and adoptive transfer of human ILC2s for the treatment of mice bearing liquid and solid tumors.
Isolation, expansion, and adoptive transfer of human ILC2s for the treatment of mice bearing liquid and solid tumors.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
2型固有淋巴细胞(ILC2s)在调节免疫反应和多种生理过程中至关重要,包括组织修复、代谢稳态、炎症和肿瘤监视。在此,我们提出了一种方案,概述了从外周血单个核细胞中分离、扩增和过继转移人ILC2s,用于小鼠模型中的体内谱系追踪实验。此外,我们详细描述了将人ILC2s过继转移至携带人血液肿瘤或实体瘤的受体小鼠的步骤。关于本方案使用和执行的完整细节,请参阅Li等人1。
Type 2 innate lymphoid cells (ILC2s) are crucial in regulating immune responses and various physiological processes, including tissue repair, metabolic homeostasis, inflammation, and cancer surveillance.
Here, we present a protocol that outlines the isolation, expansion, and adoptive transfer of human ILC2s from peripheral blood mononuclear cells for an in vivo lineage tracking experiment in a mouse model.
Additionally, we detail the steps involved in the adoptive transfer of human ILC2s to recipient mice bearing human liquid or solid tumors. For complete details on the use and execution of this protocol, please refer to Li et al. 1 .
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。